| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.3 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.3 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |